Search results
Results from the Health.Zone Content Network
NYC Health + Hospitals, officially the New York City Health and Hospitals Corporation ( HHC ), operates the public hospitals and clinics in New York City as a public benefit corporation. HHC was created in 1969 by the New York State Legislature as a public benefit corporation. [1] It is similar to a municipal agency, but has a board of directors .
US Army HHC logo. In United States Army units, a headquarters and headquarters company ( HHC) is a company -sized military unit, found at the battalion level and higher. Considered one unit, a Headquarters and Headquarters Company is essentially two elements within one company. In identifying a specific headquarters unit, it is usually referred ...
8-Hydroxyhexahydrocannabinols ( 8-OH-9α-HHC and 8-OH-9β-HHC) are active primary metabolites of hexahydrocannabinol (HHC) in animals and trace phytocannabinoids. The 8-OH-HHCs are produced in notable concentrations following HHC administration in several animal species, including humans. They have drawn research interest for their role in HHC ...
HHC Effects. Not a lot of data exists about how HHC affects your body. But it is a form of THC, and those short-term effects are well-known. THC can: Alter your senses, including your sense of ...
Website. Orlando Health. Lists. Hospitals in Florida. Orlando Health is a private, not-for-profit network of community and specialty hospitals based in Orlando, Florida. Orlando Health is Central Florida ’s fourth largest employer with nearly 29,000 employees and more than 4,500 affiliated physicians. [1]
Kings County Hospital Center is a municipal hospital located in the East Flatbush neighborhood of Brooklyn, New York City. It is owned and operated by NYC Health + Hospitals, a municipal agency that runs New York City's public hospitals. It has been affiliated with SUNY Downstate College of Medicine since Downstate's founding as Long Island ...
Hexahydrocannabinol ( HHC) is a hydrogenated derivative of tetrahydrocannabinol (THC). It is a naturally occurring phytocannabinoid that has rarely been identified as a trace component in Cannabis sativa, [1] [2] but can also be produced synthetically by acid cyclization and hydrogenation of tetrahydrocannabinol.
Hexahydrocannabivarin ( HHCV, HHC-V) is a semi-synthetic cannabinoid derivative, the hydrogenated derivative of tetrahydrocannabivarin (THCV). It was first synthesised by Roger Adams in 1942 and produces only weak cannabinoid-like effects in animals. [1] More recently it has been sold as an ingredient in grey-market cannabinoid products.